Lexicon Pharmaceuticals LXRX Goodwill impairment losses

Goodwill impairment losses at other companies

Bausch Health CompaniesBHC

$1.43B—

Fox Factory Holding Corp.FOXF

$139.33M—

KemperKMPR

$11.38M—

HarmonicHLIT

$14.38M—

Bausch Health CompaniesBHC

$1.43B—

Driven Brands Holdings Inc.DRVN

$7.08M—

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's goodwill impairment losses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's goodwill impairment losses?: Lexicon Pharmaceuticals (LXRX) reported goodwill impairment losses of $0 in Q4 2025.